CYTL1 and gastric adenocarcinoma: We uncovered the underlying mechanism, signaling pathway, and immune microenvironment of CYTL1 in STAD through multiple bioinformatics analyses and suggested that CYTL1 may act as an independent prognostic factor for STAD and regulate STAD progression by modulating the immune microenvironment.